Since of Jeff's personal experience with this medical innovation, he thinks it can change the world: "it's an incredible new trend in medication driven by technology that identified cancer. And gave me a battling opportunity to beat it incredibly early before it grew into a potentially fatal issue." Jeff doesn't just suggest buying this business to take advantage of this trend.
: "But there's more to this technology than just saving my life. By subscribing to The Near Future Report today, you can discover how this innovation works, what it does, and why Jeff thinks it will change the world of medication.
Jeff Brown utilizes Mirati Therapies as an example, which rose 8,481% in under two years. Other gains featured on The Near Future Report's sales page include: Jeff Brown is cautious to discuss that past revenues do not guarantee future results.
He does not suggest designating a substantial part of your portfolio to these stocks. However, Jeff also declares he has "visited suppliers and done his own research on future incomes" to confirm his recommendations. Based on that analysis, Jeff is positive that some of his biotech stock picks will increase substantially in the near future.
2 Trillion Market that Could Save Millions of Lives? Jeff, like lots of investors, thinks biotech will be one of the hottest tech trends over the coming years. Biotech is no trick.
Jeff discusses accuracy medication as one example: "the biotech market is expected to grow 86% over the next few years. That is remarkable. However listen to this, The precision medicine market is expected to grow 152% during that very same time" Accuracy medication is an emerging location of biotech that uses exact biological data to determine disease threat.